Rotational Stability and Clinical Response of the ASQELIO Toric Biaspheric Monofocal Lens.

NCT ID: NCT06101472

Last Updated: 2024-01-31

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

63 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-02-29

Study Completion Date

2024-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this observational study is to evaluate the rotational stability and clinical performance of the ASQELIO Toric lens in candidates for cataract surgery with ASQUELIO Toric intraocular lens (IOL) implantation.

Information will be obtained from patients operated by routine clinical practice with toric monofocal ASQELIO IOL in at least one eye. After confirmation of inclusion, the preoperative examination will be performed, and after surgery an evaluation will be performed the following day, one week, one month and three months after surgery.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In cataract surgery, the opacified lens is removed by phacoemulsification and replaced by an artificial IOL.The most common risk of cataract surgery is the development of a condition called posterior capsular opacification (PCO) that causes further deterioration of visual function. Toric intraocular lenses correct corneal astigmatism and avoid residual refractive errors in these subjects. For their efficacy in this refractive error correction, it is essential that, once implanted, these lenses are rotationally stable.The goal of this observational study is to evaluate the rotational stability and clinical performance of the ASQELIO Toric lens during the first 3 months after implantation.

All patients participating in the study are candidates for cataract surgery with ASQUELIO Toric intraocular lens (IOL) implantation model TLIO130 from AST Products, Inc., with CE marking.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cataract

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Pseudophakic subjects implanted with the ASQELIO toric IOL

Adult subjects undergoing cataract surgery by routine clinical practice with ASQELIO Toric Biaspheric Monofocal Lens in at least one eye.

ASQELIO Toric Biaspheric Monofocal Lens

Intervention Type DEVICE

Intraocular lens implantation in cataract surgery

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ASQELIO Toric Biaspheric Monofocal Lens

Intraocular lens implantation in cataract surgery

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subjects 22 years of age or older undergoing cataract surgery in at least 1 eye and implanted with LIO ASQELIO.
* Subjects for whom postoperative emmetropia was planned (±0.5 D spherical equivalent)

Exclusion Criteria

* Preoperative corneal astigmatism less than 0.75D
* Patients who do not provide informed consent
* Patients who do not understand the study procedure.
* Previous corneal surgery or trauma.
* Irregular cornea (e.g. keratoconus).
* Microphthalmos.
* Severe corneal dystrophy.
* Pregnant or breastfeeding'.
* Rubella
* Mature/dense cataract making eye bottom preoperative examination difficult.
* Previous retinal detachment.
* Concurrent participation in other research with drugs or clinical devices.
* Expect to require another eye surgery during the study period.
Minimum Eligible Age

22 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

AST Products, Inc.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Pedro Tañá, Dr

Role: PRINCIPAL_INVESTIGATOR

Oftalmología Vistahermosa SL

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Oftalvist Alicante

Alicante, , Spain

Site Status RECRUITING

OftalVist Madrid

Madrid, , Spain

Site Status RECRUITING

OftalVist Valencia

Valencia, , Spain

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Spain

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Maria Cobo, Dr

Role: CONTACT

+34963513304

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

José M Rubio, OD

Role: primary

+34965141500

Fátima Martínez Galdón, OD

Role: primary

+34915 42 60 10

Rafael Pastor Pascual, OD

Role: primary

+34963 513304

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ASQM022023

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.